AVR
Anteris Technologies Ltd
🇦🇺 ASX
🩺 HEALTH CARE
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 1.29%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
4
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. The company is headquartered in Toowong, Queensland. The company went IPO on 2004-03-24. The firm is engaged in designing, developing, and commercializing medical devices. The Company’s lead product, DurAVR, is a transcatheter heart valve (THV) for treating aortic stenosis. DurAVR THV is made using ADAPT tissue, its patented anti-calcification tissue technology. DurAVR THV is a novel first-in-class biomimetic valve made from a single piece of native-shaped tissue. The company is designed to mimic the performance of a pre-disease human aortic valve. Its balloon expandable ComASUR Delivery System provides controlled deployment and accurate placement of the DurAVR THV valve, designed to achieve precise alignment with the heart’s native commissures to achieve ideal valve positioning.
📈 Performance
Price History
-18.73%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$8.94
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AVR
4
📊 Total Capital Earnings
$-681.66
🔃 Average investment frequency
63 weeks
💵 Average investment amount
$1,176
⏰ Last time a customer invested in AVR
188 days
AVR investor breakdown
💵 Income of investors
More than 200k
150k - 200k
25%
100k - 150k
25%
50k - 100k
50%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
75%
Male
25%
Pearlers who invest in AVR also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.62%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.02%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
🙌 Performance (5Yr p.a)
2519.76%
📊 Share price
$10.54 AUD
IMU
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.
🙌 Performance (5Yr p.a)
4.67%
📊 Share price
$0.04 AUD
🧬 BIOTECHNOLOGY
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.56%
📊 Share price
$63.57 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Want more shares? Try these...
Avira Resources Ltd. operates as an exploration company, which engages in the exploration of tin, gold and copper properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2013-01-09. The Company’s e Puolalaki Project comprises a single exploration permit (Puolalaki nr 100) centered over a syn-orogenic gabbro intrusion that hosts the nickel mineralization. In addition to the Ni-Cu-Co mineralization at Puolalaki, the project also includes high-grade gold mineralization across two zones within the metasediments and metavolcanics surrounding the gabbro. The project is located in Sweden’s premier Gallivare mining district. In addition to the Puolalaki Project in Sweden, the Company holds two tenement packages within the Paterson Range province in the Northwest of Western Australia which is host to a number of substantial gold, copper and manganese mines and deposits, including the Telfer gold-copper mine. Its projects are situated in the Yeneena basin sedimentary rock formation that hosts both the Nifty and Maroochydore copper deposits and the Woody Woody Manganese mine.
🙌 Performance (5Yr p.a)
-10.00%
📊 Share price
$0.00 AUD
⛏️ MINING
American West Metals Ltd. engages in the development and exploration of mining properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-12-13. The principal activities of the Company include development of the zinc-copper-indium deposit at West Desert, Utah as well as exploration across the broader project area, expanding the high-grade discoveries at the Storm Copper and Seal Zinc Projects, Nunavut, and establishing a resource at the expansive Copper Warrior Project, Utah. The company is focused on the discovery of copper and other clean energy mineral deposits in North America. Its projects include West Desert, Storm, Seal Zinc and Silver Deposit, and Copper Warrior. The West Desert project is located in west-central Utah, approximately 160 kilometers (km) southwest of Salt Lake City. The Storm Copper Project is located on Somerset Island, Nunavut, Canada. The Project covers an area of over 4,000 square kilometers within the Polaris mineral district. The Copper Warrior project is located 45 km south of Moab, Utah, within the Paradox Basin.
📊 Share price
$0.04 AUD
⛏️ MINING
Advance Metals Ltd. engages in the business of investing in renewable energy and coal exploration. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-12-20. The firm is focused on identifying underexplored and undervalued projects with significant geological potential. The firm has 100% ownership of the Garnet Skarn Deposit, Augustus Project, and the Anderson Creek Gold Project. The Augustus Project is a high-grade copper-gold advanced exploration and development project located in Yavapai County, Arizona, United States. The project totals approximately 902 hectares (2,229 acres) and resides in approximately 125 kilometers (km) northwest of Phoenix, Arizona. The Garnet Skarn Deposit is located in Adams County, Idaho (ID), United States. The project comprises over 2,527 contiguous acres of unpatented mineral lands.
🙌 Performance (5Yr p.a)
5.12%
📊 Share price
$0.03 AUD
⛏️ MINING
